Valiant Organics Ltd reported a consolidated net profit of 290.5 million rupees on operational revenue of 2.32 billion rupees for the June quarter. The Mumbai-based specialty chemical producer also approved the re-appointment of Sathiababu K. Kallada as Managing Director for three years, according to statutory filings submitted to BSE and NSE.
MUMBAI, India — Specialty chemical manufacturer Valiant Organics Ltd announced a consolidated net profit of 290.5 million rupees ($29.05 crore) for the June quarter, demonstrating strong earnings momentum across its chlorination, ammonolysis, and specialty chemical manufacturing divisions. According to statutory financial disclosures submitted to Indian stock exchanges on Wednesday, August 12, 2026, the Mumbai-headquartered company recorded consolidated revenue from operations of 2.32 billion rupees ($232 crore) for the three-month period ending June 30. Alongside the quarterly financial results, the company's board of directors formally approved the re-appointment of Sathiababu K. Kallada as Managing Director for a three-year term, providing strategic leadership continuity as the company expands its specialty chemical portfolio across domestic and export markets.
Financial Recovery and Operational Performance Across Key Divisions
The latest quarterly figures mark a strong operational start to the fiscal year for the specialty chemical producer. Consolidated revenue from operations reached 2.32 billion rupees, supported by sustained volume off-take of agrochemical intermediates, dye intermediates, and pharmaceutical inputs.
The recorded Valiant Organics June-Qtr Consol Net Profit of 290.5 million rupees reflects improved operating margins, helped by price stabilization in key chemical feedstock inputs, improved capacity utilization across manufacturing plants in Gujarat and Maharashtra, and disciplined factory overhead controls.
Financial statements filed with stock exchanges indicate that integrated processing capabilities enabled Valiant Organics to maintain steady delivery schedules for both domestic industrial clients and international buyers. Lower energy and logistics costs during the three-month period further bolstered operating realisations, directly lifting the Valiant Organics June-Qtr Consol Net Profit figure.
Executive Leadership Continuity and Board Governance
In a parallel regulatory filing, Valiant Organics confirmed that its board of directors, acting on the recommendation of the Nomination and Remuneration Committee, approved the re-appointment of Sathiababu K. Kallada as Managing Director for a three-year period.
Sathiababu K. Kallada, who has served in executive leadership roles within the company, will continue overseeing long-term capital allocation, operational optimization, and market diversification strategies. The re-appointment is subject to approval by shareholders at the upcoming Annual General Meeting (AGM), in compliance with the provisions of the Companies Act, 2013, and SEBI regulations.
Under Kallada’s ongoing tenure, Valiant Organics has focused on enhancing production safety standards, expanding product offerings in agrochemical intermediates, and strengthening corporate governance frameworks across its manufacturing units.
Specialty Chemical Sector Landscape and Market Impact
The Indian specialty chemical industry has navigated global demand shifts, inventory adjustments in international agrochemical channels, and fluctuating chemical feedstock prices. Despite global market headwinds, domestic demand for high-value chemical intermediates used in crop protection and active pharmaceutical ingredients (APIs) has provided strong volume support for primary producers.
The dual announcement of operational earnings growth and executive re-appointment carries practical implications for industrial partners, investors, and supply chain networks:
Equity Investors and Analysts: Achieving a Valiant Organics June-Qtr Consol Net Profit of 290.5 million rupees reinforces balance sheet stability and investor confidence following prior cycles of raw material price volatility.
Industrial Supply Chains: Consistent factory operations at 2.32 billion rupees ensure steady procurement of basic chemical feedstocks while guaranteeing reliable supply to downstream pharmaceutical and agricultural formulators.
Corporate Governance Watchdogs: The seamless re-appointment of Sathiababu K. Kallada provides managerial stability and long-term strategic execution for institutional shareholders.
Official Sources Section
The financial figures and corporate governance decisions cited in this report originate from official statutory disclosures filed by Valiant Organics Ltd. The company submitted its unaudited consolidated financial results for the quarter ended June 30 in compliance with Regulation 30 and Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Official compliance filings were transmitted directly to the exchange desks at BSE Limited and the National Stock Exchange of India. Additional policy context regarding chemical sector regulations is guided by public notices from the Ministry of Chemicals and Fertilizers and macroeconomic guidance from the Ministry of Finance.
Quote Section
Commenting on the quarterly financial performance and executive leadership continuity, company representatives highlighted the firm's operational resilience.
"According to officials, the financial performance during the June quarter demonstrates the strength of our manufacturing operations and our focus on operational discipline across core specialty chemical lines. The re-appointment of Managing Director Sathiababu K. Kallada ensures strategic continuity as we continue to optimize our product mix and deliver consistent value to stakeholders."
Why It Matters
Sustained profitability and leadership stability at Valiant Organics signal positive operational health for India's broader specialty chemical ecosystem. As global pharmaceutical and agrochemical firms seek reliable supply chain partners outside traditional manufacturing regions, well-managed Indian producers with strong financial foundations and steady leadership are well-positioned to capture long-term international trade volumes.
Key Facts at a Glance
Consolidated Net Profit: 290.5 million rupees ($29.05 crore) for the June quarter.
Consolidated Revenue from Operations: 2.32 billion rupees ($232 crore) for the June quarter.
Executive Action: Board approves re-appointment of Sathiababu K. Kallada as MD for 3 years.
Corporate Headquarters: Mumbai, Maharashtra, India.
Stock Listings: BSE Limited (Security Code: 540145) and National Stock Exchange of India (Symbol: VALIANTORG).
Frequently Asked Questions (FAQ)
What were Valiant Organics' primary financial results for the June quarter?
Valiant Organics Ltd reported consolidated revenue from operations of 2.32 billion rupees and a Valiant Organics June-Qtr Consol Net Profit of 290.5 million rupees.
Who was re-appointed as Managing Director of Valiant Organics?
The board of directors approved the re-appointment of Sathiababu K. Kallada as Managing Director for a three-year tenure, subject to shareholder approval.
What products does Valiant Organics Ltd manufacture?
The company specializes in manufacturing specialty chemicals, including chlorophenol derivatives, agrochemical intermediates, dye intermediates, and pharmaceutical chemical inputs.
Where can investors access official filings for Valiant Organics?
Statutory financial releases and corporate announcements are available on the official investor portals of BSE Limited and the National Stock Exchange of India.
Source: Official regulatory disclosures filed with BSE Limited, filings submitted to the National Stock Exchange of India, corporate statements from Valiant Organics Ltd, policy releases from the Ministry of Chemicals and Fertilizers, and economic notices from the Ministry of Finance.
